Yahoo Web Search

Search results

    • AstraZeneca sets sights on $80B in revenue by 2030

      AstraZeneca sets sights on $80B in revenue by 2030

      BioPharma Dive via Yahoo Finance· 7 hours ago

      Executives are banking on extending the Farxiga franchise through fixed-dose combinations with new compounds to treat heart failure and chronic kidney...